The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6305 · Cited by 2,279
Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61904-7 · Cited by 2,217
Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
(2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.003 · Cited by 1,245
Faul, C., Donnelly, M., Merscher-Gomez, S., Chang, Y. H., Franz, S., Delfgaauw, J., Chang, J.-M., Choi, H. Y., Campbell, K. N., Kim, K., et al. (2008) · Nature Medicine · doi:10.1038/nm.1857 · Cited by 991
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Rini, B. I., Halabi, S., Rosenberg, J. E., Stadler, W. M., Vaena, D. A., Ou, S.-S., Archer, L., Atkins, J. N., Picus, J., Czaykowski, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9847 · Cited by 899
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 775
Hurwitz, H. I., Fehrenbacher, L., Hainsworth, J. D., Heim, W., Berlin, J., Holmgren, E., Hambleton, J., Novotny, W. F., & Kabbinavar, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.017 · Cited by 688
Zhu, X., Wu, S., Dahut, W. L., & Parikh, C. R. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.039 · Cited by 632
Cohen, E. E. W., Rosen, L. S., Vokes, E. E., Kies, M. S., Forastiere, A. A., Worden, F. P., Kane, M. A., Sherman, E., Kim, S., Bycott, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9566 · Cited by 623
Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria
Tryggvason, K., Patrakka, J., & Wartiovaara, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052131 · Cited by 576
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
Schrijvers, B. F., Flyvbjerg, A., & De Vriese, A. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00621.x · Cited by 504
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261164 · Cited by 466
Rixe, O., Bukowski, R. M., Michaelson, M. D., Wilding, G., Hudes, G. R., Bolte, O., Motzer, R. J., Bycott, P., Liau, K. F., Freddo, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70285-1 · Cited by 435
Atkins, R. C., Briganti, E. M., Lewis, J. B., Hunsicker, L. G., Braden, G., Champion de Crespigny, P. J., DeFerrari, G., Drury, P., Locatelli, F., Wiegmann, T. B., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.019 · Cited by 367
Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race
Mattix, H. J., Hsu, C.-Y., Shaykevich, S., & Curhan, G. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341034 · Cited by 355
Zhu, X., Stergiopoulos, K., & Wu, S. (2009) · Acta Oncologica · doi:10.1080/02841860802314720 · Cited by 312
Preeclampsia: A renal perspective
Karumanchi, S. A., Maynard, S. E., Stillman, I. E., Epstein, F. H., & Sukhatme, V. P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00316.x · Cited by 308
Lea, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.947 · Cited by 297
Managing Patients Treated with Bevacizumab Combination Therapy
Gordon, M. S., & Cunningham, D. (2005) · Oncology · doi:10.1159/000088481 · Cited by 283
Spano, J.-P., Chodkiewicz, C., Maurel, J., Wong, R., Wasan, H., Barone, C., Létourneau, R., Bajetta, E., Pithavala, Y., Bycott, P., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60661-3 · Cited by 250
Self-citationThe Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050207 · Cited by 239
Urine proteomics: the present and future of measuring urinary protein components in disease
Barratt, J., & Topham, P. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061590 · Cited by 222
Renin Angiotensin System Blockade in Kidney Transplantation: A Systematic Review of the Evidence
Hiremath, S., Fergusson, D., Doucette, S., Mulay, A. V., & Knoll, G. A. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01928.x · Cited by 207
Patel, T. V., Morgan, J. A., Demetri, G. D., George, S., Maki, R. G., Quigley, M., & Humphreys, B. D. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm311 · Cited by 192
Angiogenesis Inhibitor Therapies: Focus on Kidney Toxicity and Hypertension
Izzedine, H., Rixe, O., Billemont, B., Baumelou, A., & Deray, G. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.04.025 · Cited by 186
Self-citationThrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
Bollee, G., Patey, N., Cazajous, G., Robert, C., Goujon, J.-M., Fakhouri, F., Bruneval, P., Noel, L.-H., & Knebelmann, B. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn657 · Cited by 185
Direct effects of dexamethasone on human podocytes
Xing, C.-Y., Saleem, M. A., Coward, R. J., Ni, L., Witherden, I. R., & Mathieson, P. W. (2006) · Kidney International · doi:10.1038/sj.ki.5001655 · Cited by 159
Frangié, C., Lefaucheur, C., Medioni, J., Jacquot, C., Hill, G. S., & Nochy, D. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70037-2 · Cited by 158
Advani, A., Kelly, D. J., Advani, S. L., Cox, A. J., Thai, K., Zhang, Y., White, K., Gow, R. M., Marshall, S. M., Steer, B. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703577104 · Cited by 145
Garovic, V. D., Wagner, S. J., Petrovic, L. M., GRAY, C., Hall, P., Sugimoto, H., Kalluri, R., & Grande, J. P. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl711 · Cited by 145
Slowing Nephropathy Progression: Focus on Proteinuria Reduction
Bakris, G. L. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03250807 · Cited by 121
Hutchison, A. S., O’Reilly, D. S. J., & MacCuish, A. C. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.10.2019 · Cited by 121
Hara, A., Wada, T., Furuichi, K., Sakai, N., Kawachi, H., Shimizu, F., Shibuya, M., Matsushima, K., Yokoyama, H., Egashira, K., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000439 · Cited by 107
Tew, W. P., Colombo, N., Ray-Coquard, I., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.5508 · Cited by 105
Pathophysiology of Renal Disease.
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-542_6 · Cited by 91
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma
Roncone, D., Satoskar, A. A., Nádasdy, T., Monk, J. P., & Rovin, B. H. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0476 · Cited by 87
Thrombotic microangiopathy and anti-VEGF agents
Izzedine, H., Brochériou, I., Deray, G., et al. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl565 · Cited by 81
Self-citationAngiotensin-Converting Enzyme Inhibitors for Bevacizumab-Induced Hypertension
Dinçer, M., & Altundağ, K. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h244 · Cited by 68
Glomerular disease related to anti-VEGF therapy
Stokes, M. B., Erazo, M. C., & D’Agati, V. D. (2008) · Kidney International · doi:10.1038/ki.2008.256 · Cited by 57
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis
Blanco, S., Bonet, J., López, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.09303.x · Cited by 56
Interstitial nephritis in a patient taking sorafenib
Izzedine, H., Brochériou, I., Rixe, O., & Deray, G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm199 · Cited by 44
Self-citationAgabiti‐Rosei, E. (2003) · Drugs · doi:10.2165/00003495-200363991-00003 · Cited by 39
Tang, P. A., Cohen, S. J., Bjarnason, G. A., Kollmannsberger, C., Virik, K., MacKenzie, M. J., Brown, J., Wang, L., Chen, A. P., & Moore, M. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4027 · Cited by 37
Agabiti‐Rosei, E. (2003) · PubMed · Cited by 34
Pathophysiology of Renal Disease
Aronson, L. R., Langston, C. E., & Chalhoub, S. (2012) · Wiley eBooks · doi:10.1002/9781118997505.ch50 · Cited by 34
Cited by
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC
Le, X., Nilsson, M., Goldman, J., Reck, M., Nakagawa, K., Kato, T., Ares, L. P., Frimodt-Moller, B., Wolff, K., Visseren-Grul, C., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.006 · Cited by 339
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
Hahn, V. S., Lenihan, D. J., & Ky, B. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000665 · Cited by 264
VEGF regulates local inhibitory complement proteins in the eye and kidney
Keir, L. S., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., Welsh, G. I., Richards, A., Usui, Y., Satchell, S. C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86418 · Cited by 154
Metadata
- Authors
- Izzedine, H., Massard, C., Spano, J. P., Goldwasser, F., Khayat, D., & Soria, J. C.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 46
- Issue
- 2
- Pages
- 439-448
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2076017354
- Cited by
- 332
- References
- 61
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.